Skip to content
Independent analysis of NHS open data
PharmaInsight

Ibrutinib

Malignant Disease and Immunosuppression Cytotoxic drugs BNF 0801050BS
Data updated May 2024 Download CSV
3items

Dispensed in May 2024

0items

Rolling 12 months

£12,877

Net ingredient cost · May 2024

Figure 1. Ibrutinib: national items dispensed by month

0 2 4 Jul 2021 Nov 2021 Feb 2022 May 2022 Oct 2022 Apr 2023 May 2024 3 Jul 2021: 3 Aug 2021: 1 Nov 2021: 1 Dec 2021: 1 Feb 2022: 1 Mar 2022: 4 May 2022: 1 Jun 2022: 1 Oct 2022: 1 Jan 2023: 1 Apr 2023: 1 Aug 2023: 1 May 2024: 3

Source: NHSBSA Prescription Cost Analysis, to May 2024

Download CSV
Embed this chart

At a glance

  • Therapeutic class Cytotoxic drugs
  • Presentations 2 shown
  • Average cost / item £4,292.40
What this is
Net ingredient cost is the list price before discounts and dispensing fees, not what the NHS finally pays.

Top presentations, May 2024

The individual products dispensed under Ibrutinib this month.

Presentations of Ibrutinib, May 2024
Presentation BNF code Items Net ingredient cost
Imbruvica 560mg tablets 0801050BSBBAEAE 2 £11,446
Imbruvica 140mg tablets 0801050BSBBABAB 1 £1,431

Source: NHSBSA Prescription Cost Analysis · to May 2024 OGL v3.0

Where Ibrutinib is dispensed

The regions and dispensing practices with the highest Ibrutinib volumes.

Regional volumes from NHSBSA Prescription Cost Analysis; practice volumes from NHS dispensing data.

In NHS hospitals

Ibrutinib is also used in NHS secondary care. See the indicative hospital cost, monthly trend and the trusts using it most on the hospital medicines page.

Compare Ibrutinib with

Other medicines in the same BNF section, by prescribing volume.